ValiRx Share Price | |
---|---|
Price | 3.15 |
Bid | 3.10 |
Ask | 3.20 |
Change | 0.10 (3.28%) |
Volume | 372,590 |
Open | 3.05 |
High | 3.15 |
Low | 3.05 |
Prev. Close | 3.05 |
Currency | GBX |
---|---|
Issue Country | GB |
Shares in Issue | 132.35m |
Market Capitalisation | £4.17m |
Market Size | 30,000 |
52 Week High | 14.75 |
52 Week High Date | 03-Nov-2023 |
52 Week Low | 3.05 |
52 Week Low Date | 10-May-2024 |
# Trades | 11 |
---|---|
Vol. Sold | 110,000 |
Sold Value | £3.42k |
Vol. Bought | 262,590 |
Bought Value | £8.29k |
PE Ratio | -1.029412 |
Earnings | -3.06 |
Dividend | 0.00 |
Yield | 0.00% |
Date | Time | Trade Prc | Volume | Buy/Sell | Bid | Ask | Value | |
---|---|---|---|---|---|---|---|---|
13-May-24 | 14:44:05 | 3.19 | 17,241 | Buy* | 3.10 | 3.20 | 549.99 | O Ordinary |
13-May-24 | 14:00:58 | 3.19 | 5,297 | Buy* | 3.10 | 3.20 | 168.97 | O Ordinary |
13-May-24 | 12:19:05 | 3.112 | 110,000 | Sell* | 3.10 | 3.20 | 3,423 | O Ordinary |
13-May-24 | 12:12:27 | 3.20 | 22,812 | Buy* | 3.10 | 3.20 | 729.98 | O Ordinary |
13-May-24 | 11:00:53 | 3.188 | 53,324 | Buy* | 3.10 | 3.20 | 1,700 | O Ordinary |
13-May-24 | 10:49:39 | 3.188 | 4,643 | Buy* | 3.10 | 3.20 | 148.02 | O Ordinary |
13-May-24 | 10:38:33 | 3.188 | 10,500 | Buy* | 3.10 | 3.20 | 334.74 | O Ordinary |
13-May-24 | 10:19:38 | 3.188 | 26,662 | Buy* | 3.10 | 3.20 | 849.98 | O Ordinary |
13-May-24 | 08:54:22 | 3.15 | 72,111 | Buy* | 3.00 | 3.10 | 2,271 | O Ordinary |
13-May-24 | 08:43:21 | 3.055 | 25,000 | Buy* | 3.00 | 3.10 | 763.75 | O Ordinary |
Announced | Traded | Action | Notifier | Price | Currency | Amount | Holding |
---|---|---|---|---|---|---|---|
07-Jul-22 | 07-Jul-22 | Placing | Gerald Desler held the position of CFO at the time of this trade.Gerald Desler | 10.00 | GBX | 25,000 | 128,668 |
07-Jul-22 | 07-Jul-22 | Placing | Kevin Cox held the position of Non-Executive Chairman at the time of this trade.Kevin Cox | 10.00 | GBX | 100,000 | 372,333 |
07-Jul-22 | 07-Jul-22 | Placing | Martin Lampshire held the position of Non-Executive Director at the time of this trade.Martin Lampshire | 10.00 | GBX | 100,000 | 144,000 |
07-Jul-22 | 07-Jul-22 | Placing | Suzanne Dilly held the position of CEO at the time of this trade.Suzanne Dilly | 10.00 | GBX | 100,000 | 416,668 |
18-Feb-21 | 18-Feb-21 | Buy | Martin Lampshire held the position of Non-Executive Director at the time of this trade.Martin Lampshire | 22.70 | GBX | 44,000 | 44,000 |
Click here to read more about our shareholder information - providing intellectual, corporate and financial support in the early stages of drug development.